The Asthma and Allergy Foundation of America (AAFA) announces the election of Dr. Richard K. Murray, MD, FACP, as the new board chair. Dr. Murray has served as a leader on AAFA’s board of directors since 2016.
In the summer of 2017, Alexis Fetterman and her parents had an unexpected introduction to asthma and allergies . Alexis was 2 years old and got sick with a respiratory virus. After a visit to the emergency room, she was admitted to the hospital and flown to a nearby children’s hospital. After a few days in the hospital, Alexis was diagnosed with asthma. “The hospital stay was a really traumatic experience. Since then, I’ve immersed myself in learning about asthma and allergies. I want to...
People with asthma have more treatment choices than ever before, and the FDA recently announced approval for the readmittance of Primatene Mist – an over-the-counter (OTC) epinephrine inhaler. The Asthma and Allergy Foundation of America (AAFA) cautions patients to not stop their current asthma treatment nor start taking this OTC option without talking to their health care provider first.
The Asthma and Allergy Foundation of America (AAFA) with support provided by the U.S. Centers for Disease Control and Prevention (CDC) has created and launched the Asthma Symptoms, Treatment, Health Management and Activities™ (ASTHMA) Care for Adults program to help patients manage asthma and improve their health. The program covers a full range of topics someone with asthma needs to know.
Kadesh Incorporation Issues Voluntary Nationwide Recall of Puriton Eye Relief Drops Due to Non-Sterile Production Conditions For Immediate Release November 7, 2018 Contact Consumers Recall Department contact@puriton.us Announcement Kadesh, Inc. of Garden Grove, CA is voluntarily recalling all lots of Puriton Eye Relief Drops, 0.5 oz. (15ml) bottle, UPC 7 36972 1679 0, to the consumer level. During a recent FDA inspection, investigators observed that ophthalmic drugs, which are required to be...
FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may block access to the auto-injector and prevent the ability to easily access the product.
The Asthma and Allergy Foundation of America (AAFA) in partnership with Allergy Standards Limited (ASL) announced findings from a new market research survey aimed at better understanding patient and consumer awareness, perceptions and values of certified products and the asthma & allergy friendly® Certification Program, as well as buyer behaviors and demands.
Health care reform has been a big topic in the news for a while now. With so much news on the topic, it can get confusing, especially during the federal Health Insurance Marketplace’s (Healthcare.gov) open enrollment. Here are some things to know about health care for 2019.
If you have asthma or allergies, it is important to have health insurance. Medicine, lab tests, lung function tests and visits to see a specialist all add up. What do you need to know about your insurance options during open enrollment this year?
There are a variety of treatments for eczema, including creams and ointments. But your doctor may also recommend moisturizing methods, like "soak and seal" and "wet wrapping." These therapies can help your topical medicines be more effective. Everyone's eczema is different, and there are many ways you can manage flare-ups. Talk to your doctor about therapies that may work best for you.
The Asthma and Allergy Foundation of America (AAFA), the premiere nonprofit representing patients with asthma and allergies, applauds the recent request for information and statement from the Food and Drug Administration (FDA) demonstrating its commitment to explore the classification of sesame as a major allergen.
Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.
The Asthma and Allergy Foundation of America (AAFA) welcomes two new Executive Directors this year. David Guydan has joined the AAFA New England Chapter , and Marjorie Moore has joined the AAFA St. Louis Chapter . Guydan brings both for-profit and nonprofit experience to his AAFA role. He started with a career in banking and finance, serving as a CEO in the industry for 10 years. More recently, he worked as a strategic planning consultant for multiple nonprofits. He also held a fellowship as...
On Nov. 8, 2018, from 3-4 p.m. ET, join us for a free interactive video program on eczema. The live session will include interactive polling, real-time question-and-answer session and an expert panel featuring specialists on eczema.
Do you or close relatives have a history of asthma, allergic rhinitis (hay fever), food allergies or other allergic diseases? If so, you have a higher chance of having atopic dermatitis (AD), the most common type of eczema. These types of allergic conditions are often inherited and related. Many people with AD have at least one of these other conditions. Help us raise awareness about eczema and AD during Eczema Awareness Month by sharing the messages below on social media. Share on Social...
